Research programme: infectious disease vaccine - Vedantra Precision Immunity
Alternative Names: ICMV platform-based malaria vaccine - Vedantra Precision Immunity; Malaria vaccine - Vedantra Precision ImmunityLatest Information Update: 28 Oct 2020
At a glance
- Originator Vedantra Precision Immunity
- Class Antimalarials
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for preclinical development in Malaria in USA (Parenteral)
- 02 Sep 2016 Preclinical trials in Malaria in USA (Parenteral) before September 2016